Voir la source de I Would Say The GDC-0941 Endeavor Call : So, Who Likes Practically Nothing Is Announced The Winner?!

An anonymized database was created where patients�� age, tumor size, hormone receptor status, histologic type, histologic grade, nodal status, presence of lymphatic invasion, Ki-67 status, RS and treatment decision without and with knowledge of RS were registered. Pre-assay adjuvant therapy decisions were made in accordance to the institutions�� guidelines, [http://en.wikipedia.org/wiki/Diglyceride diglyceride] based on clinicopathologic characteristics from retrospective collected data. Although institutions��guidelines vary slightly, they were largely based on the national health insurance guidelines. Post-assay treatment recommendations were decided based on the review of Oncotype DX by each institution. However, the actual adjuvant treatment administered to each patient may differ from the recommendation, as 10 patients did not follow the entire treatment plan. Two types of analyses were performed to determine the [http://www.selleckchem.com/products/GDC-0941.html GDC 941] association of RS and clinicopathologic characteristics, as defined in the study: with RS as a continuous variable or as a discrete variable defined by low (RS,  all patients were women. The average tumor size was 1.9 cm (range, 0.6 to 5.5 cm). One hundred eighty-seven cases are invasive ductal, seven were invasive lobular, and 18 exhibited other features. Lymph-node metastasis were absent in 192 cases and present as micrometastases in 20 cases. Lymphatic invasion was absent in [http://www.selleckchem.com/products/AZD0530.html AZD0530] 140 cases and present in 48 cases. Her2 status was negative in all cases. Ki-67 was less than 14 in 135 cases and more than 14 in 59 cases. Oncotype DX assay results showed low RS of